1332 related articles for article (PubMed ID: 26509334)
1. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Minter MR; Taylor JM; Crack PJ
J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
[TBL] [Abstract][Full Text] [Related]
2. The antimicrobial protection hypothesis of Alzheimer's disease.
Moir RD; Lathe R; Tanzi RE
Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800
[TBL] [Abstract][Full Text] [Related]
3. Microglial activation occurs late during preclinical Alzheimer's disease.
Streit WJ; Braak H; Del Tredici K; Leyh J; Lier J; Khoshbouei H; Eisenlöffel C; Müller W; Bechmann I
Glia; 2018 Dec; 66(12):2550-2562. PubMed ID: 30417428
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
5. Peripheral Tumor Necrosis Factor-Alpha (TNF-α) Modulates Amyloid Pathology by Regulating Blood-Derived Immune Cells and Glial Response in the Brain of AD/TNF Transgenic Mice.
Paouri E; Tzara O; Kartalou GI; Zenelak S; Georgopoulos S
J Neurosci; 2017 May; 37(20):5155-5171. PubMed ID: 28442538
[TBL] [Abstract][Full Text] [Related]
6. Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.
Cai Z; Hussain MD; Yan LJ
Int J Neurosci; 2014 May; 124(5):307-21. PubMed ID: 23930978
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of immune regulation in Alzheimer's disease: a viewpoint.
Marx F; Blasko I; Grubeck-Loebenstein B
Arch Immunol Ther Exp (Warsz); 1999; 47(4):205-9. PubMed ID: 10483867
[TBL] [Abstract][Full Text] [Related]
8. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
Weisman D; Hakimian E; Ho GJ
Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
[TBL] [Abstract][Full Text] [Related]
9. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
Savelieff MG; DeToma AS; Derrick JS; Lim MH
Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
[TBL] [Abstract][Full Text] [Related]
10. Neuroinflammatory Cytokines Induce Amyloid Beta Neurotoxicity through Modulating Amyloid Precursor Protein Levels/Metabolism.
Alasmari F; Alshammari MA; Alasmari AF; Alanazi WA; Alhazzani K
Biomed Res Int; 2018; 2018():3087475. PubMed ID: 30498753
[TBL] [Abstract][Full Text] [Related]
11. Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms.
Sastre M; Klockgether T; Heneka MT
Int J Dev Neurosci; 2006; 24(2-3):167-76. PubMed ID: 16472958
[TBL] [Abstract][Full Text] [Related]
12. Distinct cytokine profiles in human brains resilient to Alzheimer's pathology.
Barroeta-Espar I; Weinstock LD; Perez-Nievas BG; Meltzer AC; Siao Tick Chong M; Amaral AC; Murray ME; Moulder KL; Morris JC; Cairns NJ; Parisi JE; Lowe VJ; Petersen RC; Kofler J; Ikonomovic MD; López O; Klunk WE; Mayeux RP; Frosch MP; Wood LB; Gomez-Isla T
Neurobiol Dis; 2019 Jan; 121():327-337. PubMed ID: 30336198
[TBL] [Abstract][Full Text] [Related]
13. Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.
Blasko I; Grubeck-Loebenstein B
Drugs Aging; 2003; 20(2):101-13. PubMed ID: 12534311
[TBL] [Abstract][Full Text] [Related]
14. The effects of microglia-associated neuroinflammation on Alzheimer's disease.
Wang C; Zong S; Cui X; Wang X; Wu S; Wang L; Liu Y; Lu Z
Front Immunol; 2023; 14():1117172. PubMed ID: 36911732
[TBL] [Abstract][Full Text] [Related]
15. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro.
Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P
Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic implications of gelsolin in Alzheimer's disease.
Ji L; Zhao X; Hua Z
J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
[TBL] [Abstract][Full Text] [Related]
17. Impact of Cytokines and Chemokines on Alzheimer's Disease Neuropathological Hallmarks.
Domingues C; da Cruz E Silva OAB; Henriques AG
Curr Alzheimer Res; 2017; 14(8):870-882. PubMed ID: 28317487
[TBL] [Abstract][Full Text] [Related]
18. Neuroinflammation in Alzheimer's Disease: Current Progress in Molecular Signaling and Therapeutics.
Thakur S; Dhapola R; Sarma P; Medhi B; Reddy DH
Inflammation; 2023 Feb; 46(1):1-17. PubMed ID: 35986874
[TBL] [Abstract][Full Text] [Related]
19. Deglycosylated anti-amyloid beta antibodies reduce microglial phagocytosis and cytokine production while retaining the capacity to induce amyloid beta sequestration.
Takata K; Hirata-Fukae C; Becker AG; Chishiro S; Gray AJ; Nishitomi K; Franz AH; Sakaguchi G; Kato A; Mattson MP; Laferla FM; Aisen PS; Kitamura Y; Matsuoka Y
Eur J Neurosci; 2007 Nov; 26(9):2458-68. PubMed ID: 17970733
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
